secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001104659-24-109855
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio CSO Michael Howell departs effective Oct 15, 2024; no successor named
------------------------------------------------------------------------------

- Chief Scientific Officer Michael Howell separated from Zura Bio on October 15, 2024.
- Separation not related to financial or operating results or any disagreements.
- No replacement for the CSO position has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465924109855/0001104659-24-109855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465924109855/tm2426509d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-109855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer